Human IL-23/IL-12B&IL-23A protein (Recombinant) (C-His&Avi) {Biotin} (STJP020038)

SPECIFICATIONS
HostHEK293 cells
ConjugationBiotin
ImmunogenBiotinylated Recombinant Human IL-23/IL-12B&IL-23A Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg20-Pro189 (IL-23 alpha) & Ile23-Ser328 (IL-12 beta) ) of Human IL-23 alpha&IL-12 beta (Accessi
STJP020038-100
🚚 Free UK Delivery on orders over £150
Processing The item has been added
Enquire For Bulk Order
✓ 1-Year Performance Guarantee | SDS & Datasheet Included | Expert Tech Support | Covered by St John's Laboratory Guarantee

General Information

Short DescriptionRecombinant-Human IL-23/IL-12B&IL-23A-C-His&Avi protein was developed in hek293 cells using the region Arg20-Pro189. For use in research applications.
HostHEK293 cells
NoteSTRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.

Product Properties

ConjugationBiotin
FormulationLyophilised from 0.22 Mu m filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Storage InstructionStore at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Determination Method< 1 EU/Mu g of the protein by LAL method.

Target Information

ImmunogenBiotinylated Recombinant Human IL-23/IL-12B&IL-23A Protein is produced by HEK293 cells expression system. The target protein is expressed with sequence (Arg20-Pro189 (IL-23 alpha) & Ile23-Ser328 (IL-12 beta) ) of Human IL-23 alpha&IL-12 beta (Accessi
Immunogen RegionArg20-Pro189
Immunogen SequenceRAVPGGSSPAWTQCQQLSQK LCTLAWSAHPLVGHMDLREE GDEETTNDVPHIQCGDGCDP QGLRDNSQFCLQRIHQGLIF YEKLLGSDIFTGEPSLLPDS PVGQLHASLLGLSQLLQPEG HHWETQQIPSLSPSQPWQRL LLRFKILRSLQAFVAVAARV FIWELKKDVYVVELDWYPDA PGEMVVLTCDTPEEDGITWT LDQSSEVLGSGKTLTIQVKE FGDAGQYTCHKGGEVLSHS

Additional Info

Background The interleukin (IL)-12 family of cytokines, including IL12 and IL 23, play an important role in driving aberrant Th1 and Th17 immune responses in patients with Crohn s disease (CD). Targeting this pathway has opened new avenues for therapeutic intervention. The balance of proinflammatory cytokines interleukin (IL)-12 and IL-23 plays a key role in shaping the development of antitumor or protumor immunity.

Information sourced from Uniprot.org

Citations

Product Review

Well-cited Academic Publications
KO-Validated 700+ Lines
Technical Support Expert Scientific Team
1-Year Guarantee Antibodies & Proteins